The full launch sequence from idea to live store (entity, EIN, banking, payments, sourcing, compliance, and go-live) with a copy-ready checklist.
Starting a research peptide company
The practical prerequisites (entity, EIN, banking, payments, and compliance) explained step by step by people who actually run a regulated peptide business. Start here, then let us handle the storefront, payments, and compliance tooling. For teardowns and arguments rather than instructions, see the lab logs.
The RUO Payment Processing Field Guide
A screen of roughly 28 payment processors for a research-use-only catalog: which underwrite RUO, which auto-decline it, why the “safer” merchant category code is the dangerous one, and how to vet any processor in ten minutes. Free, one email field.
Get the field guideWhy you need a real entity before anything else, choosing an LLC, getting your free EIN from the IRS, and the state registrations that follow.
Opening a dedicated business bank account, what documents you'll need, and why clean financial separation matters for underwriting and taxes.
Instant approval is not underwriting. What Stripe's policy actually prohibits, why Shopify Payments runs on the same engine, what a 90-to-180-day fund hold does to a young business, and what works instead.
Why peptides are “high-risk,” why Stripeand Shopify Payments say no, what underwriters require, and how to get approved. Start this early.
High-risk underwriting is a file review, not a credit check. The corporate records, financial history, COAs, labels, SOPs, policies, and chargeback plan that decide a peptide application, plus what they check on your storefront.
Processors hold 5 to 15 percent of daily settlements for 90 to 180 days. What that does to working capital in an inventory business, why growing faster makes it worse, and how to negotiate it down.
Terminated for cause and you can land on a database every major acquirer queries, for five years, with no appeal. What gets you listed, what processing costs afterward, and the post-termination pattern that puts sellers there.
Lot match, recency, a named accredited lab, purity plus sequence identity, and a contaminant panel. What sophisticated buyers open the certificate to verify, and why documentation is the one thing you can compete on without making a claim.
The primary risk isn't temperature alone. What to pack, why expedited air is really about capping the exposure window at 72 hours, and the equilibration step that undoes everything if a buyer gets it wrong.
One question separates a contained bad batch from a company-wide problem. The three-step linkage that answers it, why the fulfillment step is the one everyone skips, and what to decide before you need it.
The only compliance control your customer actually experiences. Five things the page has to do, example copy, and why the jurisdiction list belongs in configuration rather than in the copy.
Enforcement in this category isn't arbitrary. Three patterns recur across the public warning letters, and one of them has nothing to do with what you wrote: it's what's in the cart alongside the compound.
The structure/function versus disease line, the substantiation bar and where it's softer than people claim, the hedged phrases that don't help, and the considerable amount you can still say.
Paid social is mostly closed, so everyone turns to creators. Two compliance layers apply here, not one. What goes in the agreement, what to monitor, and why the difficulty is the moat.
RUO labeling, age and intended-use gating, restricted-state shipping, and the audit trail that keeps you on the right side of underwriting.